Dr. Patrick Leavey, MD
Claim this profileUT Southwestern/Simmons Cancer Center-Dallas
About Patrick Leavey, MD
Education:
Earned an MD (Doctor of Medicine).
Experience:
Founded a multi-disciplinary program for children with bone tumors and other sarcomas at UT Southwestern/Simmons Cancer Center-Dallas.
Was a founding member of the Sickle Cell Disease Clinical Trials Network and contributed to its development.
Played a key role in the development of the North Texas clinical trial unit for sickle cell disease.
Led the After the Cancer Experience (ACE) program, the premier pediatric cancer survivor program in North Texas.
Area of expertise
Cancer
Patrick Leavey, MD has run 7 trials for Cancer. Some of their research focus areas include:
Soft Tissue Sarcoma
Patrick Leavey, MD has run 5 trials for Soft Tissue Sarcoma. Some of their research focus areas include:
Affiliated Hospitals
UT Southwestern/Simmons Cancer Center-Dallas
University Of Texas Southwestern Medical Center
Clinical Trials Patrick Leavey, MD is currently running
Long-Term Follow-Up
for Cancer
This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.
Recruiting
1 award
N/A
3 criteria
Health Information Collection
for Childhood Cancer
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.
Recruiting
1 award
N/A
10 criteria
More about Patrick Leavey, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Patrick Leavey, MD has experience with
- Ramucirumab
- Cyclophosphamide
- Vinorelbine
- Vincristine
- Questionnaire Administration
- Bosutinib
Breakdown of trials Patrick Leavey, MD has run
Cancer
Soft Tissue Sarcoma
Osteosarcoma
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Patrick Leavey, MD specialize in?
Patrick Leavey, MD focuses on Cancer and Soft Tissue Sarcoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are SMARCB1 positive.
Is Patrick Leavey, MD currently recruiting for clinical trials?
Yes, Patrick Leavey, MD is currently recruiting for 4 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Patrick Leavey, MD has studied deeply?
Yes, Patrick Leavey, MD has studied treatments such as Ramucirumab, Cyclophosphamide, Vinorelbine.
What is the best way to schedule an appointment with Patrick Leavey, MD?
Apply for one of the trials that Patrick Leavey, MD is conducting.
What is the office address of Patrick Leavey, MD?
The office of Patrick Leavey, MD is located at: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas 75390 United States. This is the address for their practice at the UT Southwestern/Simmons Cancer Center-Dallas.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.